You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

88 search results for: coexisting diseases

Infographic

The Emerging Paradigm of Atopic Dermatitis as a Lifelong Predisposition to Episodic Skin Lesions

5 min

Dermatology

Explore how atopic dermatitis persists and advances, spanning childhood to adulthood via this informative infographic.

interactivity

Prurigo Nodularis (PN) Case Studies

5 min

Dermatology

Three interactive, educational case studies on the clinical presentation, diagnosis, and management of patients with prurigo nodularis.

expert video

The Burden and Unmet Needs of Patients With PN

6 min

Dermatology

Understand the assessment of prurigo nodularis (PN) and the importance of recognizing PN as a distinct disease – an interview with Prof. Laurent Misery.

expert video

Can advanced systemic therapies modify pathomechanisms in AD?

5 min

Dermatology

Dr. Ramien discusses evidence showing that advanced therapies can modify the mechanisms of atopic dermatitis, improving skin barrier function, normalizing the skin microbiome, and reducing chronic itch.

expert video

Can early intervention modify the course of AD?

5 min

Type 2 Inflammation

Dr. Amy Paller emphasizes that early intervention in children can alter disease progression. Depending on the severity, this can be achieved with topical interventions or systemic therapies.

Infographic

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

5 min

Gastroenterology

Learn about key drivers of type 2 inflammation in EoE and how they mediate progressive esophageal remodeling and impact patient burden

expert video

The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers

1 min

Dermatology

Discover the multidimensional impact of pediatric atopic dermatitis on children and caregivers – a soundbite from the Expert Lounge Canada 2022.

expert video

What proportion of patients can achieve control in CRSwNP?

5 min

Type 2 Inflammation

Join Prof. Hellings and Prof. Corso in dicussion on the factors affecting complete control of CRSwNP, including treatment types, comorbidities, and the need for more data on biologics.

expert video

It Takes a Village: Patient-Centered Care in Pediatric EoE

2 min

Gastroenterology

Learn from Prof. Papadopoulou as she highlights the importance of collaboration of multiple specialties in the care of pediatric EoE.

interactivity

Expert Case Series: What is the Role of Type 2 Inflammation in Skin Barrier Dysfunction Commonly Observed in Atopic Dermatitis?

10 min

Dermatology

Gain insights with Prof. Lisa Beck: Explore the link between skin barrier dysfunction and type 2 inflammation in atopic dermatitis.

expert video

Can advanced systemic therapies modify pathomechanisms in AD

5 min

Dermatology

Dr. Ramein discusses evidence showing that advanced therapies can modify the mechanisms of atopic dermatitis, improving skin barrier function, normalizing the skin microbiome, and reducing chronic itch

expert video

EAACI 2023 | Recognizing EoE in the Allergy Clinic

23 min

Gastroenterology

Join Dr. Antonella Cianferoni as she discusses how allergists can help identify EoE patients in the allergy clinic and support patient care.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region